Clinical Trial Update: Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

View source ↗

Summary

This clinical trial update reports on the genomic profiling of residual disease in advanced ovarian cancer after neoadjuvant chemotherapy. The study conducted b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Yonsei University | Conditions: Advanced-stage Ovarian Cancer | Status: COMPLETED